AUTHOR=Li Xintong , Lai Lana YH , Ostropolets Anna , Arshad Faaizah , Tan Eng Hooi , Casajust Paula , Alshammari Thamir M. , Duarte-Salles Talita , Minty Evan P. , Areia Carlos , Pratt Nicole , Ryan Patrick B. , Hripcsak George , Suchard Marc A. , Schuemie Martijn J. , Prieto-Alhambra Daniel TITLE=Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis JOURNAL=Frontiers in Pharmacology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.773875 DOI=10.3389/fphar.2021.773875 ISSN=1663-9812 ABSTRACT=

Using real-world data and past vaccination data, we conducted a large-scale experiment to quantify bias, precision and timeliness of different study designs to estimate historical background (expected) compared to post-vaccination (observed) rates of safety events for several vaccines. We used negative (not causally related) and positive control outcomes. The latter were synthetically generated true safety signals with incident rate ratios ranging from 1.5 to 4. Observed vs. expected analysis using within-database historical background rates is a sensitive but unspecific method for the identification of potential vaccine safety signals. Despite good discrimination, most analyses showed a tendency to overestimate risks, with 20%-100% type 1 error, but low (0% to 20%) type 2 error in the large databases included in our study. Efforts to improve the comparability of background and post-vaccine rates, including age-sex adjustment and anchoring background rates around a visit, reduced type 1 error and improved precision but residual systematic error persisted. Additionally, empirical calibration dramatically reduced type 1 to nominal but came at the cost of increasing type 2 error.